ConductScience.org, home

Gene · 10112

KIF20A: kinesin family member 20A

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. KIF20A: kinesin family member 20A. Genes, record 10112. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10112

On this page

Gene

Symbol
KIF20A
HGNC
Name
kinesin family member 20A
HGNC
NCBI Gene ID
10112
NCBI Gene
HGNC ID
HGNC:9787
HGNC
Ensembl
ENSG00000112984
NCBI Gene
Aliases
MKLP2, RAB6KIFL, RCM6
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
O95235Kinesin-like protein KIF20A8901Ensembl, GeneID, HGNC

Source UniProt

Patents98

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1450835O95235Espacenet
EP 4650780 A22025-11-1911209O95235Espacenet
EP 4641201 A22025-10-2911672O95235Espacenet
EP 4641202 A22025-10-295916O95235Espacenet
JP 2025517969 A2025-06-1211672O95235Espacenet
JP 2025517970 A2025-06-1211209O95235Espacenet
KR 1020250017231 A2025-02-045916O95235Espacenet
EP 4487869 A22025-01-08254O95235Espacenet
KR 1020240027895 A2024-03-04444O95235Espacenet
JP 2023536814 A2023-08-307192O95235Espacenet

1 to 10 of 98

See all 98 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants588

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleKIF20A papersNewest fiscal year
P30CA051008Georgetown University Lombardi Comprehensive Cancer Center Support Grant42025
P30CA016056Roswell Park Cancer Center Support Grant32025
P30CA016672Cancer Center Support Grant32025
R35GM119455Mechanisms of Phosphorylation Signaling by Phosphoprotein Phosphatases32025
T32CA009686Training Grant In Tumor Biology32025
I01BX002773A Novel Drug Target for Aggressive Prostate Cancer22025
P20GM113132The Institute for Biomolecular Targeting22025
P30CA013148Comprehensive Cancer Center Support Grant22025
P30CA016042Cancer Center Support Grant22025
P30CA068485Cancer Center Support Grant22025

1 to 10 of 588Source NIH's project files

See all 588 nih grants

Papers1,613

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Ionizing radiation induces senescence of dermal papilla cells through inhibiting the FOXM1-KIF20A pathway.Genes Dis202742733528PubTator, text miningPubMed
Identification of functional genes and immune cell infiltration analysis in liposarcoma.PLoS One202642726806PubTator, text miningPubMed
Microplastics and nanoplastics-related genes signature predicts prognosis in pancreatic ductal adenocarcinoma and functional validation of interleukin 1 alpha.Transl Cancer Res202642724844PubTator, text miningPubMed
Identification of a cholesterol metabolism-related signature based on KIF20A and NDC80 for prognostic stratification and immunotherapy prediction in hepatocellular carcinoma.Cancer Biomark202642685023PubTator, text miningPubMed
MicroRNA Signatures of Fulvestrant-Treated Luminal Breast Cancer Cells: Identification of Therapeutic Targets Regulated by miR-374b-5p.Int J Mol Sci202642589442PubTator, text miningPubMed
Kinesins in Bladder Cancer: Integrating Molecular Mechanisms and Treatment Approaches.Cell Biol Int202642529891PubTator, text miningPubMed
Unveiling immune-related gene signatures in triple negative breast cancer through integrated transcriptomic analysis.Biomedicine (Taipei)202642483440PubTator, text miningPubMed
Targeting mitotic kinesin KIF20A: A differentiation-based therapeutic strategy for glioblastoma stem/progenitor cells.Stem Cell Reports202642462712PubTator, text miningPubMed
KIAA1429 promotes gallbladder cancer progression through m6A-dependent post-transcriptional modification of KIF20A.Sci Rep202642437826PubTator, text miningPubMed
Large-scale transcriptome analysis reveals KIF20A as a novel indicator of cisplatin resistance in high-grade serous ovarian cancer.J Ovarian Res202642426841PubTator, text miningPubMed

1 to 10 of 1,613

See all 1,613 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/10112

GET https://conductscience.org/api/genes/v1/10112/patents?page=2